Table Of Content

Author’s Index A Bobek, S. 252 Ceriello, A. 347 Dyrberg, T. 510 Bocian-Sobkowska,J . 30 Chambers, C. A11 Abdel Aziz, H. A16 Bode, H.-P. 572 Chambert, G. 577 E Abdel-aleem, S. 430 Boivin, S. A2, A4 Chast, F. A4 Abdul-Latif, H. 172 Boland, R.L. 231 Chaurasia, S. S.15 i, 932 Eberhardt, E. 604 Abela, C. 387 Bolinder, J. A7, 440 Chellaram, R. 483 Ebert, T. 572 Adachi, K. 427 Bonfatti, D. A9 Chen, R. L. A6 Ecker, A. 604 Adamec, M. A17 Bordignon, C. A13 Chesnokova, V. 88 Eckhard, M. A10 Aguado, L.I. 242 Bornstein, S. R. 30, 373 Chevalier, A. A19 Eckhard, T. A5, A15 Ahmed, S. A7 Boschero, A. C. 220 Cilli, M. 247 Edris, A. A1l6 Aida, K. 646 Boselli, C. A9 Cinci, G. 504 Edwall, L. 393 Alessis, C. A3 Bosello, 0. 458 Cirino, A. 472 Ehrhart-Bornstein, M. 30 Allendorfer,J . 510 Bouanani, M. A2 Ciurlino, D. A9 El-Atrozy, T.S. A17 Ammar, A.A. A16 Boucek, P. A17 Clemente, F. 417 El-Awady, M.K. 430 Ammermann, D. 237 Boudjema, K. A16 Clodi, M. 387 El-Migdadi, F. 196 Amrouni, H. A17 Boullier, A. A3 Coassin, S. 247 El-Ouaghlidi, A. A10, A15, A18 Anapliotou, M. 115 Boullu, S. A2 Collette,| . 549 Elgrably, F. A18 Andersen, F.G. 265 Bozikov, V. 355 Collins, E.D. 231 Ellmerer, M. A8 Andreas,J . 584 Brandhorst, D. A5, A10, A13, Coppelli, A. A5, A13, A14 Endl,J . 403 Andrikopoulos, S. 311 A15, A18 Cornelius, |. G. 271 Ernst, W. A10 Angelini, G. 458 Brandhorst, H. A5, A10, A13, Corominola, H. 60 Escobar-Jiménez, F. 566 Annovazzi, A. 261 A15, A18 Cosimi, S. AS Escobar-Morreale, H. F. 358, Antwerp, W.P. van A7, All Breidert, M. 30 Costa, A. 477 409 Arai, T. 469 Brelje, T.C. 301 Cottini, E. 472 Etchegoyen, G.S. 84 Araujo-Vilar, D. 561 Brendel, M. A10 Coughlan, A. 323 Etoh, T. 46, 530 Arezzini, L. 504 Bretzel, R.G. A5, A10, A13, A15, Couvaras, O. A10 Armellini, F. 458 A16, A17, A18, 510 Crepaldi, S.C. 220 F Arner, P. A7 Bringer, J. A2 Cryer, P.E. 92 Arrhenius-Nyberg, V. 20 Brosa, U. 70 Culler, F.L. 172 Falqui,L . A13 Arvat, E. 180 Broux, R. 549 Curiale, V. A14 Federlin, K. AS, A10, A13, A15, Asaka, S. 360 Brownie, A.C. 196 Cushman, S.M. 255 Al17, A18, 510 Aschoff, A. 535 Bruggink, J.E. 25 Cwik, C. 379 Fehmann, H.-C. 572 Ashcroft, S.J.H. 355 Brun, J.M. 193 Cybal, M. A16 Fernandez-Pardo, |. 520 Ashida, K. 407 Brunetti, P. A9 Czaijkowski, K. A19 Ferrara, C.M. 214 Asmah, B.]. 580 Brunner, G. A8 Ferrari, G. A9 Aulak, K.S. 214 Bruno, G. 180 D Fickova, M. 16 Aussedat, B. A8 Bruzzo, F. A4, A19 Findlay, D. M. 128 Azevedo, M.]. de 516 Bufalari, A. A9 D'Alessio, D. 297, 311 Fiore C.E. 472 Azukari, K. 407 Bundshu, D. All Damante, G. 347 Fleisch, H. 145 Burchell, A. 97 Darquy, S. A6, A8, A11, A12, A15 Forsling, M.L. 477 Burden, A.C. A10 Dawood, M.Y. 483 Forst, T. 584 Busch, K. 111 De La Pena, A. 66 Friedman, J.E. 214 Balsa, J. 409 Busick,J . 88 De Leo, T. 225 Friemann, S. A10 Bardin, C. A4 Del Guerra, S. A5, A13, A14 Frier, B.M. 197 Barnas, U. 387 Cc Del Zotto, H. 84 Fries, F.A. 436 Bartos, V. A17 Delacroix, L. 549 Fruchart, J.-C. A3 Bashir, N. 196 Cabezas-Cerrato,J . 561 Delaunay, C. A8, A15 Fujisawa, T. 56 Basta, G. A9 Calabrese, M. A5 Delbachian, I. A3 Furlan, R. A13 Baumgartner-Parzer, S.M. 613, Calafiore, R. A9 Demirdjian, S. A4 Furukawa, K. 360, 611 636 Caldara, R. A9 Dennison, A.R. A10 Fyssas, I. 115 Beales, P.E. 261 Calle-Pascual, A.L. 450 Di Carlo, V. 1, A9 Belaich, S. A13 Camanni, F. 180 Di Meo, S. 225 G Belcourt, A. A9 Capron, F. A& Dieli, M. 472 Belicer, P. A3 Cararach, V. 60 Doi, H. 530 Gagel, R. F. 135 Bensbaho, K. 549 Cardona, F. 60 Doorn, L.G. van A4 GagliardinoJ.,J . 84 Berg, A.-L. 475 Carmellini, M. AS Doorn, T.T. van A4 Ganz, M. 403 Bergis, K.H. 510 Carneiro, E.M. 220 Dorange, C. A4 Garcia-Estan,J . 520 Berne, C. A4 Carneiro, R.C. 363 Dordevic, P.B. A14 Garcia-Estevez, D.A. 561 Berra, C. A13 Carrasco, M. 242 Downing, R. A6, A12 Garcia-Robles, R. 566 Bertaina, S. 180 Caschetto, S. 472 Doyle, J.W. 43 Gasic, S. 12 BeyeJr].5 ,84 Castoldi, R. A9 Drouin, P. A3 Geissler, K. 387 BicanJ, . All Catargi, B. A3 Druzynska,J . A16 Gerritsen, M. All Bicikova, M. 465 Caumo, A. A9 Duguid, W. 278 Ghigo, E. 180 Bissoli, L. 458 Cavallo, M.G. 403 Duijvestijn, P.H.L.M. A19 Giannarelli, R. A5, A13, A14 Bitar, M. 383 Cazenave, J.P. A16 Dunan, D. 614 Giménez, M.S. 159 Bittscheid, H. AS Cecchetti, P. AS Duriez, P. A3 Gin, H. A3 Blachowicz,J . A19 Cerci S. 247 Duvivier, V. A6 Giorgini, A. 261 29 (1997 Author's Index Gleichmann, H. 403 Kaplitt, M. 599 arsson L.-l. 265 Gmyr, V. A A Kar, A. 151, 532 assmann-Vague, V. A3 Gobbi, ¢ Karim, A.M. 430 au, D. A15 Goke, B Karl, A. 572 aurberg, P. 106 Golematis Karsten, V. A9 e Borgne, C. A3 Gomis, R. 6( lannacone, A. 2) 4 Kasamatsu, Y. 407 efebvre, J. AG, A13, A17, A18 Gonzalez, O. Igarashi, M. 444 Kashiwagi, A. 491 efébvre, P. 549 Gonzalez-$ Ikegami, H. 56 KafSpohl-Butz, S. 80 egros, J.J. 549 Gotoda, T Imamura, T. 46, 530 Kato, |. 46, 530 Lemkes, H.H.P.J. 50 Gottardo, G. 86, Imhof, B.A. 614 Kato, N. 9 emonnier, F. A8 Gouin,I naba, T. 50 Kawahara, K. 593 emosquet, S. 556 Graier, W.! rahara, M. 184 Kawai, Y. 153 encioni, C. A9, A1l3 Grimelius, shibashi, N Kawamura, M. 507 eprat, F. A3 Grooteclaes, M Ishii, C. 9 Kawazu, S. 9 ernmark, A. 264 Gross, ].L. 516 Ishizuki, Y. 351 Kayama, M. 427 etizia, C. 247 Grossman, A. 4 Kelm, C. A10 evy, |. 60 soda, I 999 Grossmann, R sotani, H. 360, 611 Kerr-Conte, |. A8, A13, Al7, Al8 lang, Yin 255 Grulet, H. A3 Kerr-Conte, ].A. A6 Jone, L. A1l4 to, H. 469 Grybos, R. 101 Ito, Y.9 Kessler, L. A9, A16 ippert, T.H. 80 Guadenucci, P Itoh, Y. 351 chalid, B.A.K. 580 ondon, N.J.M. A10, A12 Guerci, B. A3 vanova, | Khamis, Y. A16 Onnroth, P. 344 Guignier, F. 193 Khan-Dawood, F.S. 483 cord, P. All wase, K Gupta, P. 151 zumi, M Kikkawa, R. 491 orenzetti, M. Al3 <inalska, I. 168 owe, |.E. 430 H ‘itamura, K. 46, 530 uca, G. A9 clein, |.-C. A8 Luger, A. 387 I jaan, B.J. de A5 ‘lempnauer,J . A5 sukaszuk A16 t daardt, M.]. A4 ‘leopoulos, S. 599 Lukie, L.J. A14 } jagen, J.J. All <nobloch, J. A5 Lupi, R. A5, A13, Al4 I lagstrom-Toft, E. A7, affiol,¢ Knode, O. 436 utterman,J . All Id akim, N.S. A17 ahr, H Kobayashi, S. 454 Lutun, E. A16 F amada, M. 351 akobsen, P. E. Koiwaya, Y. 46, 530 Lopez,E . 358, 409 akobson, G. 88 I nada, Y. 56 Komeda, K. 9 } nmes, H.-P. 643 James, R.F.L. A6 Kondo, M. 407 I ampl, R. 465 Janczewska,E . A19 Konstandoulakis, M. M. 115 M danada, Y. 530 janeczko, D. A19 Kordowiak, Anna M. 101 4Janaire-Broutin,H . A10 Janin, M. A& <osolcharoen, P. 33 ‘Bemba, J. A19 Hanson, U. 393 anott, J. 1\ 11 All Kostner, G.M. 622 Maassen, ].A. 50 ara, T. 593 Jansen, J.A. Al Kostoglou-Athanassiou,| . 477 Maccario, M. 180 Hashimoto, T. 38 anson, A. 164 Kotake, M. 351 Macho, L. 16 Hattori, S. 599 ay, T.R. A6, A12 Kotzmann, H. 387 adsen, O.D. 265 atziagelaki, E. 510 eandidier, N. A2, A4 Koziec, Ko 202 Mahgoub, M.A. A16 Hatzoglou, M. 214 ensen, J. 265 Koznarova, R. Al7 Maiti, P. K. 151 jayakawa, N. 351 Jensen, P.B. 265 Kraemer, F.B. 524 Malaisse, W.]. 60 ayashi, R. 351 estin,A . A6, A12 Kramer, R. All alendowicz, L.K. 30 Heald, K.A ilma, B. 627 Kretowski, A. 168 Malmlof, K. 20 irikowski, G.F. leidbreder, E. 7 Kruse-Lee, C. A7 ano, T. 351 eindl, |. 387 Johansson, H. Krzymien,J . A19 archetti, P. A5, A9, A13, Al4 ohn, H. 237 Heinzl, H. 387 Kumai, T. 454 Marcouyeux, C. Al0 Johnson, P.R.V. Hering, B.J. A10, A15, A17, A18 Kumar, A. 501 Marcus, C. 164 Jones, E.M. 308 ernandez, |. 520 Kuroki, T. 38 Marinello, E. 504 Hidaka, H. 491 ergensen, L.N Kusunoki, M. 593 Marinissen, M.]. 231 Hill, M. 465 Kvasnicka, T. 544 Martin, S. 639 illebrands, J.L. A5 jOrNs, A. A5 Kwok, S. 524 Martin, T. J. 128 Hiller, W.F.A. A5 otic, A. A14 Martina, V. 180 Jozwicka,E . A19 HirooYk.a 4,27 L Martinez-Blazquez, A. 520 Jullien, V. A18 Hodzic, D. 549 Masakado, M. 38 Hoeck, H. C. 106 La Rocca, E. A9 Mastrototaro, J.J. A7 Hoermann, R. 176 K Lacombe-Bessiere, S. A10 Matejka, G. 193 HoheiselG,. 373 Ladyzynski, P. A19 Mathieu, R. A8 Holst, J.J. 411 Kahn, S.E. 311 Lahrer, E. A6 Matschinsky, F.M. 255 Honiger, j. A8, A15 Kameoka, K. 360, 611 Lalic, K. A14 Matsuki, M. 153 Hoogma, R.P.L.M. A4 Kameyama, K. 184, 422 Lalic, N.M. A14 Mazzocchi, G. 86, 190 Horcher, A. A16 Kaneko,T . 203 Lamberti, S. A9 McCarty, D.J. 323 Horiuchi, T. 469 Kangawa, K. 46 Landau, B. R. 334 McCune, S.A. 214 Hosoi, E. 184, 422 Kann, P. 584 Landgraf, R. 403 Meacham, L.R. 172 Hoss, U. A7, All Kanse, S.M. 643 Landt, M. 403 Mehmetcik, G. 63 Houwing, H. 25 Kao, K.-]. 271 Larkins, A.P. A6 Melki, V. A10 Author’s Index Meranda, D. : 3: 3 Nussdorfer, G.G. 86, 190 Preissner, K.T. 643 Mercuri, F. 34 Nuutila, P. 337 Press, M. A17 Meyer, C. A18 Proye, C , Meyer, L. A3 oO Puddu, A Micciolo, R. 458 Milgram, M. A4 Ogihara, T. 56 Q Milingos, N.115 Oh, C.-S. 363 Minejima, I. 593 Ohba, K. 496 Quevedo-C Minne, H.W. 76 Ohno, T. 9 Quiles Mino, A. 458 Ohno, Y. 184 Mishra. S.K. 379 Oliveros, L.B. 242 Mitsuma, T. 427 Onaya, T. 646 Miyachi, T. 469 Ono, Y. 38 Mobbs, C. 599 Orsetti, A. A2 N oberg, E. A7, 440 Oster, A. 265 N ohammad, M.]. 196 Mohlig, M. 111 Pp olina, A.S. 159 onroy,B . All acheco-Rosado, | I onti, L. A9 -adberg, W. A10 f Viorell, M. 66 agliaro,L . 317 Rauch, | Viori, M. 469 alacios, N. 409 Raue,f ori, S. 444 Paladini, A. 159 Reach, G orlens, P.A. A3 almer, A. A17 oro, M. 347 Pannarale, M.R. 247 lorvan, Y. 193 Pannovic, |. Al4 losca, F. A5 apadopoulos, S. 115 oulin,B . A16 apalois, V.E. A17 ueck, A.O. 80 ark, S. 214 uller, W All apiano, C. 261 Mulliez, E. A8, A13 torino, A. Al4 Als tou, F. AG, A8, Al Mundy,G . R. 120 _B. A2 furaki, T. 496 os,F . 409 uscat, E. A8 k, A.B. 271 emonte, A. Al4 RivereauL N ersen, E.E. 265 Robbi, R. 4‘5‘. 8 ellissier, L. A8 Robertson. G.S.M. A10 Nagai, R. 9 Pellizzari, L. 347 Rochlitz,Z H. 111 Nagasaka, A. 3 1 erea, A. 417 Rocic,f 2 HieaP ogo s Nakagawa, Y. 5 b erez-MartinA, . A2 Roden, M. 332 Nakai,A . 351 ,erros, P. 197 Rohmer, |.F. 193 Nakajima, K. 398 ersson, B. 393 Rolland, E. A8 Nakamura, T. 469, 593 ,etersen, H.V. 265 Rosenberg, L. 278 Nakura, H. 454 Petit, J.M. 193 Rosenfeld, M. 599 Nappi, G. 477 Petraglia, F. A14 Rossmanith,W . G. 604 Natu, V. 524 Pfeifer, M. 76 Roth, T.P. 43 Nauck, M.A. 411 Pfeiffer, A. 111 Rouault, C. A1l2 Naujoks, H. 70 Pfeiffer, E.F. A7, All Rubio, V. 66 Navalesi, N. A9 Pfeiffer, G. A15, Als Rulquin, H. 556 Navalesi, R. A5, A13, Al4 Pfeilschifter, ]. 119 Russell, R.G.G. 138 Navarra, P. 477 Pfiitzner, A. 584 Nawata, H. 38 Pieber, T. A8 S Negishi, M. 646 Piedrola, G. 358 Nicolaides, A. A17 Piepkorn, B. 584 Sai, P. A6, A12 Sumitomo Niederle, B. 387 Pinget, M. A2, A4, A9, A16 Saito, H. 184, 422 Susanto, F. 436 Niezgoda, J. 252 Pittenger, G. 278 Saito, S. 184, 422 Suylichem, P.T.R. van Al ) Nilsson-Ehle, P. 475 Pizzichini, M. 504 Saito, Y. 444 Syrigos, K. N. 115 Nishida, S. 153 Piédrola, G. 409, 566 Salgado, M. A7 Szelachowska, M. 168 Nishio, Y. 491 Plé, A. A6, A13, A17, A18 Salgado, M.I. All Nogimori, T. 427 Poindron, Ph. A9 Sandelin, K. 544 T Nomoto, T. 496 Pollaehne, W. 76 Sano, T. 38 Norazmi, K. 580 Posch, K. 622 Santi, G. 247 Tabarin, A. A3 Nord, E. 393 Postlethwaite, A. 379 Santiago,] . 403 lagliabue, M. 180 Norman, A.W. 231 Pottier, M. A18 Sarvetnick, N. 308 Takahara, N. 491 Novo, E. 566 Pozza, G. 1, A9, A13 Satta, M. A. 477 Takahashi, K. 444 Numano, F. 398 Pozzilli, P. 261, 403 Saudek, F. A17 Takeda, Y. 444 Horm. Metab. Res. 29 (1997) Author's Index TTaamkuerkaa,w a,M . K.3 9586 Vv Ww X Tan, T.T. 580 Vadgama, P. A7 Wach, P. A8 Xia, Y. A6 Tanaka, A. 398 Vague, Ph. A3 Wagner, O.F. 627 TTaannaakkaa,, SM.. 549594 VVaaillvlearndte,, G.I . 411973 WWaalgdoh,d auTs. l4,2 7W . 12, 387 v TTTaaatuuebbieesr,h, i ,D J.. T-.PA .1 47A5 140 Vvaann d5e0dw eanl lOeu,w eBl.a nA1d3, J. M. W. WWWaaannngg ,, N aSWz.. a 3i15m14 o4o n, W.M. 580 YYYaaammmaaatsdaoak,,i ,E N.. R 5.56 0 178 4, 422 TTaaywlaotra,, D.MA.. 644360 VVaernedliat,t i,C . P3. 5282,5 409 WWaasschhiemri,nT.eC,. H6.2 24 6 YYaozkaokii,, Y.Y .4 2570 7 Tchernev, V. 271 Verchere, C.B. 311 Watanabe, M. 454 Yokoo, S. 407 TTTeeelllil,ic nhiG,m. aCn3.n4 7,A 5,A .AT1. 3,8 0 A14 VVVieeasrctgaeevrsag,,a aBr.Pd ., 1A 953, P . A1l046 WWWeaabtxsatmneaarb,ne ,,JA .. Y P.1. 1 559 077 YYYooossnhheiiddoaak,,a , MT..K .4 1045730 7 Teresa, M.L. de 566 Vidal,J . 60 Weimar, K. A10 You, S. A6 ‘Tte rHzaurot,l i,L .ML.. 55004 Vill4a1n7u eva-Penacarrillo, M. L. WWeeisslsy,, JM.. 331 76 Yui, K. 398 TTohdoemséc-o,D urT.e t4,5 8 V. A8 VViinniakm, brA.e s2,7 8 C. 417 WWheistteg,r enS.,A . MA.1 03 93 Z TTTTooookmmpeiorhn,na aomg,G,a. ,6SD ..3 M9A. 6 444 VVViilvvaiisaaannkiio,,v aVG,.. L.1Z 9.3A 1A41 7 WWWihieiestceezlso,er lelMk,., L .R .ER.A. 1 2625 25 5 ZZZaaammmabukodlniaior,-, HeMM.r. n 4aA51n84d ez, S. R. Voice, M. W. 97 Wild, T. 403 S77 TTlorrraatjyoaninoaolrsidk,,i ,C P.. ZYA.. 9A A81 8 VVVooosns,k- ,SP c.h Mde.epW e.ArASk. e uAt1e2r , G. H. WWWiiilllsllomensm,,s eGnB..,S .4 1P1Ah 8. 549 ZZZaaernkoeoilrkln,o, , WT.S..A B.A. 1 624 3310 TTTrsszucokhsao,he apRre.a, , 1 0D1. F . 641936, 631 VuCciAcl,2 M. 355 WWoijnckilcekri,, RJ.. A51499 ZZhiamom,e tX,. -].P . 337233 Wolf, P. A16 Zirinis, P. A4 Wolfahrt, S. 604 Zorad, S. 16 U Wozniak, W. 30 Zumpano, E. 180 Wronska-Fortuna, D, 252 Uchida, Y. 496 Wutte, A. A8 Uchimura, K. 351 Wojcikowski, C. A16 Ueda, H. 56 Umeda, F. 38 Utsugi, T. 9 Uysal, M. 63 Subject Index A anaplastic carcinoma 351 atherogenic index 454 androgen biosynthesis 465 atherosclerosis 63, 398, 430, 491, 507, 566 o cells 271 \4-androstenedione 115 dehydroepiandrosterone sulfate 566 regulation 297 pancreatic adenocarcinoma 115 effect of macrophage colony-stimulat- acarbose 407, 411 anesthesia 66 ing factor 507 acid phosphatase 138 enflurane 66 ATP ACTH 475 hormonal effects 66 islet content A5 short test 106 angiotensin converting enzyme (ACE) 153 production in human islets A13 action potential 225 inhibitors 516 atrial natriuretic hormone rat papillary muscle fibers 225 angiotensin | 153 regulation of secretion effect of iodothyronines 225 angiotensin II 153 role of atrial pressure Addison’s disease 120 1,5-anhydro-D-glucitol 9 atrial pressure 33 adenoassociated viral vehicle 599 glycosuria 9 atrial nat gene transfer 599 IDDM 9 autoimmunity 403 adenocarcinoma 115 serum level 9 pancreatic 115 IDDM 9 pituitary hormone levels 115 animal experiments sex hormone levels 115 baboons 483 271, 294, 301, 308 adhesion molecules 631, 636 chicken 231 like peptide 19/2 apoptosis 636 Isa Brown 252 deficient insulin-releasing ) ) ) gestational diabetes mellitus 627 dairy cows 556 hyperglycemia 636 domestic fowls 86, IDDM 627, 636 mice 496 NIDDM 627, 636 Balb/c 88 role in diabetes mellitus 613 balb/c] 646 bacitracil role in metabolic disorders 627 C57 BL/6 56 Dacteria pression soluble 639 DBA/2 | 646 balloon catheterization 444 diabetes mellitus type 1 639 non-obese diabetic (NOD tery 444 adipocytes 16, 164 Swiss 151, 532 infant 164 Swiss albino 462 adipose tissue 214, 417, 524 rabbits dietary regulation 542 New Zealand white 237 very low density lipoprotein receptor Watanabe heritable hyperlipidemic 524 507 microdialysis 344 rat binding studies 604 rat 417 albino Oxford AO/G bioartificial| glucose metabolism 417 BB 584 yochemic effect of GLP-1(7 -36)amide 417 BB/Work Tky 9 bone metabolism 1 glucose transport 417 HLR 454 bis(oxalato joxovanadate(IV effect of GLP-1(7 36 )amide 417 Holtzman 242 adrenal cortex 30 SHHF/Mcc-fa 214 fetal development 30 Sprague Dawley 20, adrenal medulla 30 Sore fetal development 30 WBN/Kob 584 adrenal steroids 566 Wistar 16, 84, 97, 101, adrenocortical cells 190 427, 444, 501, 593 effect of catecholamines 190 antigonadotrophic effect 501 adrenocorticotropic hormone (ACTH) 358, Mycobacterium tuberculosis 501 373, 409, 475 antiinsulin antibodies A2 adrenomedullin 46, 530 epitopic specificity A2 marrow 1, 128 cardiac secretion 55 30 antiinsulin immunogenicity A3 cultures 128 precursor 46 insulin pumps A3 effect of calcitonin 128 advanced glycation end products 636, 643 antioxidant activity 63 transplantation | alacepril 153 hypercholesterolemia 63 metastasis 120 alanine 556 antioxidative defence system 363 frequency 120 aldosterone 153, 190, 580 cellular 363 mineral density 76, 584 aldosterone, thyroid disease 580 melatonin 363 IDDM 584 alendronate 120, 145 apoptosis 363, 535, 544 NIDDM 584 alkaline phosphatase 138, 159, 469 adhesion molecules 636 resorption 138, 145 bone metabolism 138 parathyroid adenoma 544 biochemicald markers 138 amino acids 556 arginine 220, 556 inhibition 145 insulin response 556 L-arginine 184 turnover 584 dairy cows 556 effect on immunoreactive growth hor- IDDM 584 amylin 311 mone-releasing hormone 184 NIDDM 584 AN69* bioartificial pancreas A8 arginine-vasopressin 297 bovine aortic endothelial cells 38 implantation in pigs A8 arthritis 155 bradykinin 38, 153, 622 omental pouch A8& aspartine 556 brain 197 Horm. Metab. Res. 29 (1997) Subject Index effect of hypoglycemia 197 cell shrinkage 535 coronary heart disease 111 brain-derived neurotropic factor 294 cellophane wrapping 278 corpus luteum breast cancer 120, 155 islet cell neogenesis 278 baboon 483 bone metastasis 120 cephalic phase A9 effect of interleukin-41883 broadband ultrasound attenuation 76 insulin release A9 on progesterone secretion 483 brown adipose tissue 496 cerebral atrophy 197 on prostaglandin F,,, secretion 483 monosodium glutamate-obese mice magnetic resonance imaging (MRI) 197 micro-retrodialysis 483 496 chemokines 614, 631 pseudopregnant rabbits 237 brush border membrane 159 chemotactic effect A9 corticosteroid 475 encapsulated islets A9 corticosterone 25, 190, 465 C chemotaxis A9 corticotropin 88 murine macrophages A9 corticotropin releasing hormone A14, 358, C cell 135 encapsulated islets A9 373, 477 C peptide 411 cholecystokinin A 297 corticotropin-releasing hormone-binding Slet autograft function A10 cholecystokinin B 297 protein (CRH-BP) 373 CA 125 A3 cholesterol 176, 193, 454 binding sites 373 insulin pumps A3 o-hydroxylase activity 176 biological effects 373 Ca-* signalling 622 hyperthyroidism 176 distribution 373 cadmium toxicity 151 hypothyroidism 176 expression 373 calcaneus 76 chromatin condensation 535 molecular structure 373 ultrasound analysis 76 chromogranin A 30 pregnancy 373 calcification 11 145 fetal development 30 cortisol 92, 106 inhibition 145 chronic heart failure 155 response to insulin tolerance test 106 calciotropic hormones 128 chronic inflammation 639 Crohn’s disease 631 receptors 128 chronic pancreatitis 115 crosslinks 138 calcitonin 120, 128 sex hormone levels 115 bone metabolism 138 receptor 128 chronic renal failure 70 pyridinoline 138 isoforms 128 calcium-parathyroid hormone regula- cryopreservation calcium 220 tion 70 porcine islets Al1 calcium-parathyroid hormone regulation ciglitazone 203 CS-045 203 70 cilazapril 153 NIDDM 203 chronic renal failure 70 ilostazol 491 Cu/Zn superoxide dismutase 351 calmodulin 379 effect on monocyte chemoattractant Cushing's syndrome 172, 358, 409 calorimetry protein-1 production 491 hormonal studies 355, 409 indirect 12 clodronate 120, 145 cutaneous incidents/problems A3 carbohydrate utilization 12 Coca-colonization 323 insulin pumps A3, A10 fat utilization 12 cognitive dysfunction 92, 197 cyclic AMP 491 gas exchange measurements 12 hypoglycemia 92 cystine 556 captopril 153, 516 ‘oherent microcapsules A9 cytokines A18, 111, 507 effect on glomerular filtration rate in islet allo-/xenografts A9 IDDM 516 cold exposure 496 D carbachol 220 thyroxine 5'-deiodinase activity 496 carbohydrate collagen 138 6 cell intake bone metabolism 138 regulation 297 day-to-day variability 450 ‘ollagenase darglitazone 203 metabolism 172 monoclonal antibodies A6 deafness 50 effect of glucocorticoids 172 storage Al2 maternally inherited diabetes 50 utilization 12 ollagenase solvents A6 mitochondrial DNA 50 indirect calorimetry 12 effect on islet isolation A6 decapeptyl 472 carbon monoxide 477 ‘ongenital leukocyte adhesion deficiency defective glucose counterregulation and role in neuroendocrinology 477 614 hypoglycemia unawareness 92 cardiovascular autonomic neuropathy 631 congestive heart failure 46, 430 defective vector 599 cardiovascular disease 430 proadrenomedullin N-terminal 20 adenoassociated viral vehicle 599 L-carnitine 430 peptide 46 dehydroepiandrosterone sulfate 566 carnitine-acyltransferase 436 connecting peptide (C peptide) 411 atherosclerosis 566 carotid artery 444 continuous peritoneal insulin infusion A2 hyperinsulinemia 566 rat 444 continuous subcutaneous insulin infusion ischemic heart disease 566 effect of pioglitazone on smooth A4 5'-deiodinase 496 muscle cell density 444 long-term impact A4 delapril 153 castrated rats 504 contraction 593 deoxypyridinoline 138 effects of estradiol 504 rat hindlimb muscle 593 deuterium oxide (*H,O) 334 on fatty acids 504 copper 63 development on triglycerides 504 cord blood 184 pancreas 308 catabolism 20 immunoreactive growth hormone- dexamethasone 20, 97 catecholamines 25, 84, 190 releasing hormone 184 regulation of kidney glucose-6- catecholamines 84 Cori-cycle 436 phosphatase 97 cell adhesion molecules 614 coronary disease 566 Subject Index regulation of liver glucose-6-phospha- with retinopathy 247 effect on thyrotropin 66 tase 97 endothelin-1247 englitazone 203 diabetes mellitus 347, 430, 622 total plasma oxidant status 355 enzyme localization 317 and Prader-Willi syndrome 611 troglitazone 2{§3 glucokinase 317 applications of PET 337 tumor necrosis factor@ 111 enzyme- liinln ked immunosorbrle} n t as Say gestational (GDM) 60, 393 diabetic ketoacidosis 360 ELISA) 403 adhesion molecules 627 diabetic neuropathy 510 GAD antii bodies 4t0U35 insulin response 393 glutamic acid decarboxylase antibodies epidemiologic transition I»Z) insulin sensitivity 393 510 epidemiology 155 mitochondrial glycerophosphate diabetic retinopathy 643 NIDDM in Asia 323 dehydrogenase 60 integrin chatter 643 NIDDM in Pac ific islands 32 impaired wound healing 383 diapedesis 614 obesity 155 effect of IGF-I 383 diet 84 epidermal grow maternally inherited 50 effect on sympathetic nervous system epinephrine 92, 190 and deafness 50 84 epite stosterone 465 mitochondrial DNA 50 sucrose-rich 84 ct on 116-hydroxysteroid dehyd non-invasive study of metabolism 332 dietary regulation 524 genase 465 role of adhesion molecules 613 very low density lipoprotein recepto1 e>s sennttiidail | hypertension 61 diabetes mellitus type | (insulin-depen- 524 hvYpYI erinsull dent, IDDM) A14, A17, A18, 1,9 , 25, 50 mouse heart 524 insulin re 92, 101, 168, 180, 197, 247, 261 (8 , mouse fat 524 340, 355, 403, 440, 450, 510, 5 digestion estradiol 60 585, 627, 631, 639 of pancreas A6 elfect on fatty acids, casti da1tl¢€ rats adhesion molecules 627, 636 dihydralazin 465 elfect serotonin| 1etabolism 80 1,5-anhydro-D-glucitol 9 1,25-dihydroxyvitamin D 23 469 OpaUSal W bone mineral density 584 diltiazem 38 x] lycerrriiddeesc S dt 4 bone turnover 584 discordant islet xenografts Al4, 1 rats 504 effect of growth hormone releasing effect of CRH Al4 pancreatic adel 10Cal hormone 180 diuretics with pyridostigmine 180 effect on 11B-hydroxysteroid dehydro- without pyridostigmine 180 genase 465 first degree relatives 168 DNA fragmentation 535 interleukin-12 168 L-DOPA 184 GAD antibodies 403 effect on immunoreactive growth hor- growth hormone levels 180 mone-releasing hormone 184 islet-after-kidney transplantation A10 duct cells 308 metformin 261 duplex Doppler sonography A17 multiple daily insulin injections A4 arterial flow in pancreatic graft / \17 nutritional pattern 450 oxidation of remnant-like particles 398 E plasma uric acid 355 pregnant women A19 EBi053 145 renal metabolism of uric acid 520 edema 614 simultaneous islet-kidney transplanta- enalapril 153 regulation of tion A10 8-endorphin 373 lipoprotein soluble adhesion molecules 639 endothelial adhesion molecules 636 total plasma oxidant status 355 regulation in glycemia 636 diabetes mellitus type II (non-insulin- endothelial cells 491, 622, 636 430, 504 dependent, NIDDM) 50, 56, 84, 111, damage 247 f estradiol 5 155, 203, 247, 311, 323, 355, 379, 398, diabetes mellitus 247 castrated rat 407, 411, 436, 450, 561, 572, 627, 631 endothelial cell adhesion molecules 614 oxidation 430 adhesion molecules 627, 636 endothelial dysfunction 622 fetal calf serum A6 bone mineral density 584 endothelial leukocyte adhesseia on avoidance in human! bone turnover 584 molecule-1 (ELAM-1 636 fetal devel CS-045 203 endothelial vasoactive response 622 chromogranin A 30 effect of voglibose on glycemic hyperglycemia 622 17a-hydroxy lase 30 excursions 407 endothelin-1247 fetoplacental circulation 184 epidemiology NIDDM with retinopathy 247 immunoreactive growtn hormone Asia 323 endothelium 614 releasing hormone 184 Pacific islands 323 endothelium-derived relaxing factor 622 fluorescence polarization 159 etomoxir 436 endotoxins A15 foam cells 507 glucagon-like peptide-1 therapy 411 effect on islet survival A15 follicle stimulating hormone (FSH 115, islet amyloid deposits 311 energy expenditure 436 237 nutritional pattern 450 effect of etomoxir 436 pancreatic adenocarcinoma 115 oxidation of remnant-like particles 398 enflurane 66 follicular adenoma 351 plasma uric acid 355 effect on growth hormone 66 follicular carcinoma 351 prevalence 323 effect on prolactin 66 free fatty acids 172, 3937 Horm. Metab. Res. 29 (1997) Subject Index free radicals 363 open microflow A7 determination by '*C NMR scavenger 351 regulation spectroscopy 340 melatonin 363 glucagon-like peptide-1 receptor synthesis 340 fura2 38 gene 56 glycosuria 9 furosemide 580 glucagon receptor gene 56 1,5-anhydro-D-glucitol 9 effect on 116-hydroxysteroid sensor Golgi membrane preparations 101 dehydrogenase 465 percutaneous All liver 101 fusion protein 524 subcutaneous A7 insulin-like effects of bis(oxalato) calibration A8& oxovanadate(IV) 101 G skeletal muscle A7 granulosa cell 501 insulin-induced hypoglycemia A7 progesterone production 501 galactosyl hydroxylysine 138 subcutaneous adipose tissue A7 Graves’ disease 351 galactosyltransferase insulin-induced hypoglycemia A7 growth factors 308, 544 liver Golgi 101 transport 16, 417 human recombinant 20 galanin 297 effect of thyroxine 16 parathyroid adenoma 544 gamma-aminobutyric acid (GABA) 427 rat adipose tissue 417 platelet-derived 120 effect on TRH release from rat retina 427 effect of GLP-1(7 - 36)amide 417 growth hormone (GH) A14, 92, 106, rat retina 427 transporter 16 180, 184, 294, 297, 301, 358, 422, gas exchange experiments 12 effect of thyroxine 16 646 indirect calorimetry 12 uptake 255, 337, 593 effect of enflurane anesthesia 66 gaseous neurotransmitters 477 quantification by PET 337 effect of pyridostigmine 180 gastric emptying 411 utilization 379 infant adipocytes 164 gastric inhibitory polypeptide 411 glucose-6-phosphatase 97 lipolytic effects 164 gastrointestinal hormones 297 kidney 97 regulation of mouse glycine N-methyl- gene expression regulation by dexamethasone 97 transferase 646 obesity (ob) gene 214 liver 97 response to insulin tolerance test 106 effect of exercise 214 regulation by dexamethasone 97 secretion during sleep 422 gene therapy 599 glucose-dependent insulinotropic (poly)- growth hormone releasing hormone 180, gene transfer 599 peptide 297, 411 184, 422 insulin gene 599 glucose-dependent insulinotropic proglu- cord blood 184 genetic obesity 214 cagon-derived peptide (7 - 36) amide effect of L-arginine 184 gestational diabetes mellitus, see diabetes {GLP-1(7- 36)amide] 417 effect of L-DOPA 184 glomerular filtration rate 516 effect on glucose transport in rat effect of somatostatin-14 184 effect of captopril in IDDM 516 adipose tissue 417 fetoplacental circulation 184 glucagon 56, 92, 297, 411 effect on glucose metabolism in rat secretion during sleep 422 glucagon receptor gene 56 adipose tissue 417 gynecology 66 regulation by glucose 56 o-glucosidase inhibitors 407 hormonal effects of enflurane glucagon-like peptide-1 (GLP-1 56, 297, GLUT1 255 anesthesia 66 411,572 GLUT2 255 NIDDM therapy 411 pancreatic B-cell glucose metabolism H rat pancreatic B-cells 572 255 ucagon-like peptide-1 receptor gene 56 GLUT4 16 H-411 E cells 379 regulation by glucose 56 glutamate dehydrogenase 60 heart 524 glucagonoma 265 glutamic acid decarboxylase (GAD) 403 dietary regulation of very low density ucocorticoids 20, 97, 172, 465 glutamic acid decarboxylase (GAD 65 lipoprotein receptor 524 nitrogen balance 20 antibodies A17, 403, 510 rate 225 glucokinase 317 diabetic neuropathy 510 effect of iodothyronines 225 localization 317 ELISA 403 heat stress 252 ucokinase regulatory protein 317 prediction of IDDM 403 hyperglycemic effect 252 gluconeogenesis 334 residual beta-cell function 510 action of reverse triiodothyronine stable isotope techniques 334 RIA 403 252 glucose 66, 220, 556, 566 glutathione peroxidase 351 lipemic effect 252 control A4 glycemia 636 action of reverse triiodothyronine i.v., insulin infusion A4 regulation of endothelial adhesion 252 counterregulation 92 molecules 636 hematopoietic progenitor cells 387 metabolism 255, 417, 430 ycemic control 450, 520 Hemocue blood glucose photometer A19 pancreatic B-cells 255 glycemic thresholds 92 hemodialysis GLUT2 255 yceraldehyde 3-phosphate 347 continuous on-line i. v. glucose monitor rat adipose tissue 417 effect on protein/DNA interaction 347 ing All effect of GLP-1(7 -36)amide 417 glycerophosphate dehydrogenase 60 Hep G2 cells 475 insulin response 556 mitochondrial 60 hepatic lipase 475 dairy cows 556 glycine 556 hepatocytes 379 monitoring 440 glycine N-methyltransferase 646 growth factor 278 continuous A11 mouse 646 herpes virus vector A13 Hemocue blood glucose photometet sexual dimorphism 646 gene transfer to bovine islets A1l3 A19 slycogen hexamethylenetetramine 334 on-line continuous i.v. A11 hepatic 340 hexokinase D 317 Subject Index Horm. Metab. Res. 29 (1997) XV hexokinase IV 317 primary 120, 387 i.v. glucose control A4 high altitude 458 effect of parathyroidectomy 387 Lispro A4 hip joint 76 secondary 70 stability A4 proximal right 76 caused by chronic renal failure 70 multiple daily injections A4 broadband ultrasound attenuation 76 hypertension 153, 561 diabetes mellitus type | A4 speed of sound 76 pathophysiology A9 pens histidine 556 hyperthyreosis 16 Humaject* A19 homeodomains 3476 hyperthyroidism 16, 176 Novolet*® A19 hormones 66 cholesterol 7@-hydroxylase activity 176 promotor factor-1 (IPF-1) 265 hormone replacement therapy 80 hyperuricosuria pumps A2 HT29 cells 549 hypocalcemia 70 antiinsulin immunogenicity A3 insulin-like growth factor system 549 hypoglycemia 92, 106, 197, 440, 549, 556 CA 125 A3 Humaject® A19 brain sequelae 197 catheter dysfunction A2 human chorionic gonadotrophin 501 cognitive dysfunction 92 cutaneous problems A3, A10 human diploid fibroblast cell cultures 38 detection by microdialysis 440 dysfunction A2 human ductal cell cultures A13 effect on brain 197 improved insulin All optimization A13 insulin-induced A7 insulin Lispro A7 human microvascular endothelial cells 48 physiological responses 92 receptors 16 effect of hyperglycemia 48 hypoglycemic alarm system A8 effect of thyroxine 16 effect of insulin 48 hypothalamic alpha-2 adrenergic receptors release A9 human placental lactogen 297 84 cephalic phase A9 humoral autoimmunity 510 hypothalamic-hypophyseal-gonadal axis resistance 172, 311, 379, 426, 444, 566 humoral hypercalcemia of malignancy 120 dysfunction 115 essential arterial hypertension 561 7a-hydroxy-4-cholesten-3-one 176 pancreatic cancer 115 ischemic heart disease 566 116-hydroxyandrostzenedione 465 hypothalamic-pituitary axis 373 resistance syndrome 193 3-hydroxybutyrate 393 hypothalamus 477 Lewis phenotype 193 5-hydroxyindoleacetic acid 80 gaseous neurotransmitters 477 response 393, 556 urinary excretion 80 hypothyroidism 176, 580 gestational diabetes mellitus 393 postmenopausal women 80 cholesterol 7o-hydroxylase activity to amino acids + glucose 556 hydroxyl radical 363 hypouricemia 520 dairy cows 556 17a-hydroxylase 30 secretion Al4, Al5, 220, 572 fetal development 30 cultured neonatal rat islets 220 hydroxylysine glycosides 138 effect of prolactin 220 hydroxylysylpyridinoline 138 ibandronate 120, 145 yancreatic islets from SPF pigs A hydroxyproline 138, 383 ICAM, see intercellular adhesion molecule -enancy 301 bone metabolism 138 IDDM, see diabetes mellitus type 1 ivity 172, 337, 561 metabolism 138 idiopathic pituitary dwarfism 422 ct of etomoxir 436 11$-hydroxysteroid dehydrogenase 465 IFNy transgenic mice 308 ssential arterial hypertension 561 hyerthyroxinemia 16 islet regeneration 308 sestational diabetes mellitus 393 Hyperamine 556 ilotropin 278 tors of change 172 hypercalcemia 70, 120 immunocytochemistry 604 1 test 566 causes 120 placenta 604 multiple myeloma 469 immunohistochemistry 30 A18 pathophysiology 120 human fetal adrenals 30 est 106 hypercalcemia of malignancy 120 immunomodulation 373, 631 ponse 106 management 120 immunostaining 231 hormone respon hyperchlosterolemia 63 cultured chick myoblasts 21>I insulin-| tion 101 antioxidant activity 63 impaired glucose tolerance 323 vanadate c¢ lipid peroxidation 63 impedance 458 insulin-like growt vitamin C/cholesterol ratio 63 incadronate 145 insulin-like vitamin E/cholesterol ratio 63 incretin effect 297, 572 549 hyperglycemia 43, 180, 252, 311, 454, 556, indirect calorimetry 12 effect on wound healing 1 622 carbohydrate utilization 12 ecombDinant 2)U adhesion molecules 636 fat utilization 12 ike growth factor-Il 278 effect on human microvascular endo- gas exchange measurements 12 overexpression 549 thelial cells 43 infants 164 mesothelioma 549 endothelial vasoactive response 622 adipocytes 164 parental imprinting 54 reversal 278 inferior petrosal sinus 358 promoter usage 549 hyperglycemic hyperosmolar nonketonic selective bilateral catheterization 358 insulin-like growt Nn factor Dil syndrome 360 inflammation 614 549 hyperglycemic hyperosmolar syndrome inorganic phosphorus 460 insulin-like growth factol 360 insulin 16, 20, 25, 43, 264, 297, 311, 411, HT29 colon adenocarcinoma hyperinsulinemia 561, 566 440, 572 mesothelioma 549 dehydroepiandrosterone sulfate 566 effect on human microvascular endo- term placenta 549 essential arterial hypertension 561 thelial cells 43 insulinoma 265 hyperlipidemia 454 gene regulation 265 insulinotropic effects 297 hyperparathyroidism 70, 120 infusion A4 insulitis 261 XVI Horm. Metab. Res. 29 (1997) Subject Index integrins 614 coherent microcapsules A9 lactogenic hormones 301 chatter 643 survival A14 LDL oxidation A3 diabetic retinopathy 643 islet amyloid deposits 311 intraperitoneal insulin infusion §-integrins 631 islet amyloid polypeptide 311 A3 intercellular adhesion molecules islet amyloidogenesis 311 lead 532 ICAM-1 614, 627, 636 islet autograft function A10 effect on type-1 iodothyronine soluble 639 C peptide A10 5'-deiodinase activity 532 ICAM-2 614 islet cells lectins 614 ICAM-3 639 antibodies A17 Lemmark, Ake 91 pepe ioe interleukin-1 138, 297 bovine Al13 leptin 214, 572, 611 interleukin-10 120 spontaneous disaggregation and effect of exercise on expression 214 interleukin-16 i20, 168, 483 reaggregation A13 Prader-Willi syndrome 611 interleukin-2 88 human rat pancreatic B cells 572 interleukin-6 120, 138 endocrine differentiation A13 leptin receptor 572 interleukin-12 168 neogenesis 278 leucine 220, 556 IDDM first degree relatives 168 cellophane wrapping model 278 leukoaraiosis 197 interrenal glands 86 during fetal development 278 leukocyte function-associated antigen-1 steroid production 86 in post-natal period 278 (LFA-1) 639 enhancement by pituitary adenylate induction 278 leukocyte migration 614 cyclase-activating peptide 86 neurotrophin 294 basic mechanism 614 intestinal alkaline phosphatase activity receptors 294 Lewis antigen phenotype 193 159 peptide hormone regulation 297 insulin resistance syndrome 193 intimal thickening 444 islet progenitor cells 271 lipids rat carotid artery 444 islets, transplantation 1 composition 159 effect of pioglitazone 444 cost analysis 1 fluidity 159 intraperitoneal insulin infusion indications 1 peroxidation 63, 151, 563 LDL oxidation A3 intraportal A18 hyperchloesterolemia 63 iodothryonines 225 intrathymic A5 lead induced 532 effect on heart rate 225 metabolic results 1 peroxide 351, 398 effect on rat papillary muscle fibers 225 prevascularized solid support A5 lipogenesis 379 ischemic heart disease 566 type I diabetes mellitus 1 lipolysis 164 dehydroepiandrosterone sulfate 566 islet xenografts A9 lipoprotein 454, 504 insulin sensitivity 566 coherent microcapsules A9 high density 454 oxidation of remnant-like particles 398 . islet-after kidney transplantation A10 low density 454 islets 255 IDDM A10 very low density 4543, 524 ATP content A5 islet-like clusters 271 Lispro A7 bovine A13 isoleucine 556 stability A4 gene transfer to Al3 isoprenaline 164 liver 97, 496 culture A6 lipolytic effects 164 glucose-6-phosphatase 97 in absence of fetal calf serum A6 isopropyldiiodothyronine 22! regulation by dexamethasone encapsulated A9 isoxazolidine derivatives 203 97 chemotactic effect A9 Golgi membrane preparations 101 erowth 301 J insulin-like effecotf s bis(oxalato regulation 264 oxovanadate(IV) 101 human |]i ndex 407 metabolism 340 ATP production A13 effect of voglibose in NIDDM 407 NMR studies 340 isolated fetal A14 JTT-501 203 stable isotope techniques 340 isolation thyroxine 5'-deiodinase activity 496 effect of collagenase solvents AG K low T; syndrome 252 microencapsulation L-type Ca** channels 38 alginate-polylysine-alginate A16 keratin 278 lumbar spine 76 effect of donor species A16 6-keto-prostaglandin F,,, 38 broadband ultrasound attenuation neonatal rat 220 ketosis 300 76 insulin secretion 220 severe 360 speed of sound 76 effect of prolactin 220 kidney 97, 496, 520 luteal cells 237 porcine A8, Al2, A15, A17 glucose-6-phosphatase 97 luteal phase cryopreservation A11 regulation by dexamethasone 9 —/ endocrinology 237 effect of serum A15 plasma uric acid 520 physiology 237 encapsulation A8 thyroxine 5'-deiodinase activity 496 luteinizing hormone (LH) 115, 237 long-term culture A12 transplantation 1 pancreatic adenocarcinoma 115 natural macrocapsule A16 lymphocytes 60 survival A15 L mitochondrial glycerophosphate regeneration 38 dehydrogenase 60 in IFNy transgenic mice 38 lactate 172 lysine 556 islets of Langerhans 264 dehydrogenase 462 lysylpyridinoline 138 pregnancy 301 isozyme pattern 462 islet allografts A18 lactation 159